A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: Current therapeutic options and potential applications-Reference-Cited by-同舟云学术

A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: Current therapeutic options and potential applications

Published:2021-09 Issue: Volume:907 Page:174291
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Song Danni,Zhao Xu^ORCID,Wang Fuqi,Wang Gang

Publisher

Elsevier BV

Subject

Pharmacology

Reference96 articles.

1. SAT0356 The therapeutic efficacy of the novel uricosuric agent UR-1102 for hyperuricemia and gout;Ahn;Ann. Rheum. Dis.,2014

2. Stronger uricosuric effects of the novel selective URAT1 inhibitor UR-1102 lowered plasma urate in tufted Capuchin monkeys to a greater extent than benzbromarone;Ahn;J. Pharmacol. Exp. Therapeut.,2016

3. Population pharmacokinetics and exposure-uric acid analyses after single and multiple doses of ABT-639, a calcium channel blocker, in healthy volunteers;An;AAPS J.,2015

4. Effect of Eurycoma longifolia stem extract on uric acid excretion in hyperuricemia mice;Bao;Front. Pharmacol.,2019

5. Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study);Bardin;Ann. Rheum. Dis.,2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salinomycin, a potent inhibitor of XOD and URAT1, ameliorates hyperuricemic nephropathy by activating NRF2, modulating the gut microbiota, and promoting SCFA production;Chemico-Biological Interactions;2024-11

2. Effect of Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of SHR4640, a Selective Human Urate Transporter 1 Inhibitor;The Journal of Clinical Pharmacology;2024-08-14

3. Plantaginis Semen Ameliorates Hyperuricemia Induced by Potassium Oxonate;International Journal of Molecular Sciences;2024-08-05

4. Structural basis for the transport and substrate selection of human urate transporter 1;Cell Reports;2024-08

5. Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemia;Bioorganic Chemistry;2024-06